Dr. Atul Mathur

• Dr. Atul Mathur has over 41 years of experience in interventional cardiology, making him one of the most trusted cardiologists in India. He is the Executive Director of Interventional Cardiology and the Chief of the Cath Lab at Fortis Escorts Heart Institute in New Delhi, where he leads a team of experts in advanced heart treatments.
• Dr. Mathur is the first Indian doctor to receive a US patent for a medical device used in Carotid Artery Stenting. He was also the first doctor in India to perform Carotid Stenting in 1999, a groundbreaking procedure that has since saved countless lives and is now a standard treatment across the country.
• He completed his MBBS from the University of Rajasthan, Jaipur, followed by MD in General Medicine from the University of Rajasthan. He then completed his DM in Cardiology from the All India Institute of Medical Sciences (AIIMS), Delhi, where he honed his expertise in heart care.
• With vast years of experience, he specialises in Endovascular procedures such as Aortic Graft Stenting and Peripheral Arterial and Venous Angioplasty, which are used to treat blockages in blood vessels throughout the body, improve circulation and reduce risks.
• Dr. Atul Mathur is an expert in Structural heart interventions, including Transcatheter Aortic Valve Replacement (TAVR), Mitra Clip, Left Atrial Appendage Occlusion (LAAO), Balloon Mitral Valvuloplasty (BMV), and Adult VSD closure. These procedures provide life-saving options for patients with severe heart conditions, often without the need for open-heart surgery.
• Dr. Mathur has established a Centre of Excellence in Carotid interventions, where he trains hundreds of doctors from across India to perform life-saving procedures, ensuring that more patients benefit from the latest advancements in heart care.
• Over the years, Dr. Mathur has published more than 100 research articles in prestigious medical journals. His research is widely recognised by both Indian and international experts.
• He is also a member of several leading medical organisations, including the Indian Council for Carotid Interventions, Cardiovascular Therapeutics India, and the Global Advisory Board for the Resolute Endeavour Program, contributing to the development of new treatments and standards in cardiology worldwide.
• For those in need of cardiological care, Dr. Atul Mathur at Fortis Escorts Heart Institute offers expert treatment and personalised care that patients trust. For further queries, you can contact our patient care team at this given number +91-9310356465.

• MBBS - University of Rajasthan, Jaipur, 1984.
• MD - General Medicine - University of Rajasthan, 1987.
• DM - Cardiology - All India Institute of Medical Sciences, 1991.

• Presently - Chairman of the Cardiology Department at Fortis Escorts Heart Institute.
• 1997 - 2019 Director of Cardiology at Fortis Escorts Heart Institute.
• 1992 - 1997 Assistant Professor at All India Institute of Medical Sciences.
• 1995 - 1997 Associate at the University of Alabama at Birmingham.

• Indian Council for Carotid Interventions.
• Cardiovascular Therapeutics India.
• Global Advisory Board for Resolute Endeavour Program.

Q1. Who is Dr. Atul Mathur?

He is a leading interventional cardiologist with 41+ years of expertise, known for complex angioplasty, stenting, and structural heart procedures at FEHI, Delhi.

Q2. What are Dr. Atul Mathur's key specialties?

Advanced angioplasty, TAVR, carotid stenting, peripheral interventions, and structural heart treatments like MitraClip and LAAO.

Q3. Does Dr. Mathur treat international patients?

Yes, he regularly treats global patients, and FEHI offers assistance with travel, visa, stay, and complete international patient support.

Q4. How experienced is Dr. Atul Mathur?

He has over 41 years of experience and is recognized as a pioneer in carotid stenting and advanced interventional cardiology in India.

Q5. Where can patients consult Dr. Atul Mathur?

He is available at Fortis Escorts Heart Institute (FEHI), Delhi, with appointment booking options for both Indian and international patients.